J. Pujol-Montcusi

Fast and sustained improvement of patient‐reported outcomes in psoriatic patients treated with secukinumab in a daily practice setting

A. Martorell, D. Vidal, P. Coto-Segura, 2022, Dermatologic therapy.

Swimming pool contact dermatitis caused by 1‐bromo‐3‐chloro‐5,5‐dimethyl hydantoin

P. Gaig, A. Giménez-Arnau, J. Pujol-Montcusi, 2012, Contact dermatitis.

Multicenter Retrospective Study of Secukinumab Drug Survival in Psoriasis Patients in a Daily Practice Setting: A Long-Term Experience in Spain

A. Martorell, M. Llamas-Velasco, D. Vidal, 2021, Dermatology and Therapy.

Modalidades de fototerapia para el tratamiento de la dermatitis atópica: revisión sistemática de la literatura

I. García-Doval, A. Pérez-Ferriols, Y. Gilaberte, 2015 .

Phototherapy in atopic dermatitis: a systematic review of the literature.

I. García-Doval, A. Pérez-Ferriols, Y. Gilaberte, 2015, Actas dermo-sifiliograficas.

Secukinumab is effective and safe in the long‐term treatment of plaque psoriasis in a daily practice setting: Multicenter study in 384 Spanish patients

A. Martorell, D. Vidal, P. Coto-Segura, 2022, Dermatologic therapy.

Swimming pool contact dermatitis caused by 1‐bromo‐3‐chloro‐5,5‐dimethyl hydantoin

P. Gaig, A. Giménez-Arnau, J. Pujol-Montcusi, 2012, Contact dermatitis.

Pharmacogenetic biomarkers for secukinumab response in psoriasis patients in real-life clinical practice.

F. Abad‐Santos, J. Sánchez-Carazo, P. de la Cueva, 2023, Journal of the European Academy of Dermatology and Venereology : JEADV.